Catheter ablation versus antiarrhythmic drugs with risk factor modification for treatment of atrial fibrillation: a protocol of a randomised controlled trial (PRAGUE-25 trial).
Pavel OsmancikŠtěpán HavránekVeronika BulkováJan ChovančíkTomáš RoubíčekDalibor HeřmanZuzana ČarnáVladimír TukaMartin MatoulekMartin FialaOtakar JiravskýSylvie Stregl-HruskovaAdam LatiňákJiřina KotryováJiří JarkovskýPublished in: BMJ open (2022)
ClinicalTrials.gov Registry (NCT04011800).
Keyphrases
- catheter ablation
- atrial fibrillation
- left atrial
- left atrial appendage
- risk factors
- oral anticoagulants
- randomized controlled trial
- clinical trial
- study protocol
- direct oral anticoagulants
- phase ii
- acute coronary syndrome
- coronary artery disease
- replacement therapy
- combination therapy
- drug induced
- venous thromboembolism
- double blind